OVERVIEW

Community Practice Connections™: Identifying and Treating Patients With TGCT: Best Practices for the Multidisciplinary Team is organized by Physicians' Education Resource, LLC (PER).

Release Date: June 30, 2019
Expiration Date: June 30, 2020

Target Audience:
This educational program is primarily directed toward orthopedic surgeons, sarcoma specialists, and oncologic surgeons who diagnose and/or treat patients with TGCT. Additionally, medical oncologists, fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals interested in the diagnosis, treatment, and management of TGCT are invited to participate.

Accreditation/Credit Designation:
Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Activity Overview:
Tenosynovial giant cell tumors (TGCTs) come with particular challenges because the initial presentation of symptoms is nonspecific and slowly progressing, creating difficulties in distinguishing this disease from other causes of similar symptoms. This activity will review the pathophysiology and the current and emerging therapeutic options available to patients diagnosed with TGCT. Clinical expert William Tap, MD, will discuss the challenges regarding the identification and delayed diagnosis of this disease, and how to properly evaluate patients in order to improve recognition of this rare oncologic condition. Focus will be primarily on current treatment paradigms in the context of new developments, especially as relates to the colony-stimulating factor 1 receptor (CSF1R) inhibitors, which are currently in late-stage clinical development. In addition, this program will inform best practices in multidisciplinary management and care coordination to reduce diagnostic delays and optimize outcomes for patients with TGCT.

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Explain the challenges associated with differential diagnosis of TGCT and methods to facilitate its earlier diagnosis
• Evaluate recent clinical trial efficacy and safety data of novel pharmacologic therapies for TGCT
• Develop evidence-based treatment plans for the various forms of TGCT
• Describe the role of multidisciplinary management as a best practice to optimize diagnosis and outcomes for patients with TGCT.